{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:37:22Z","timestamp":1773232642299,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bpobgyn.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T12:44:36Z","timestamp":1651236276000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"PB","title":["Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-7105","authenticated-orcid":false,"given":"Daniele","family":"Santi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio R.M.","family":"Granata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/andr.12502","article-title":"European Academy of Andrology guideline management of oligo-astheno-teratozoospermia","volume":"6","author":"Colpi","year":"2018","journal-title":"Andrology"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/humrep\/13.3.596","article-title":"Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial","volume":"13","author":"Kamischke","year":"1998","journal-title":"Human Reproduct (Oxford, England)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/andr.13123","article-title":"Are sperm parameters able to predict the success of assisted reproductive technologies? A retrospective analysis of over 22000 ART cycles","volume":"10","author":"Villani","year":"2021","journal-title":"Andrology"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/andr.12973","article-title":"Spontaneous pregnancies among infertile couples during assisted reproduction lockdown for COVID-19 pandemic","volume":"9","author":"Villani","year":"2021","journal-title":"Andrology"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2022.04.004_bib5","first-page":"23","article-title":"Male infertility treatment in the light of evidence-based medicine","volume":"28","author":"Leifke","year":"1996","journal-title":"Andrologia"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib6","series-title":"Endocrinology of the testis and male reproduction. Endocrinology","article-title":"Primary and secondary hypogonadism","author":"Santi","year":"2017"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0015-0282(16)57619-5","article-title":"Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male","volume":"63","author":"Kliesch","year":"1995","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12894-020-00674-7","article-title":"Circulating sex hormone levels in relation to male sperm quality","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Urol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/andr.12746","article-title":"FSH Treatment of male idiopathic infertility: time for a paradigm change","volume":"8","author":"Simoni","year":"2019","journal-title":"Andrology"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.04.004_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40618-018-0843-y","article-title":"The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)","volume":"41","author":"Barbonetti","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.04.004_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.eururo.2021.08.014","article-title":"European association of Urology guidelines on male sexual and reproductive health: 2021 update on male infertility","volume":"80","author":"Minhas","year":"2021","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.04.004_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072270","article-title":"FSH for the treatment of male infertility","volume":"21","author":"Casarini","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib13","article-title":"Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles","volume":"9","author":"Santi","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.04.004_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1210\/endo.141.5.7456","article-title":"The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction","volume":"141","author":"Abel","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng0297-201","article-title":"Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility","volume":"15","author":"Kumar","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmg.2017.04.004","article-title":"Novel FSHbeta mutation in a male patient with isolated FSH deficiency and infertility","volume":"60","author":"Zheng","year":"2017","journal-title":"Eur J Med Genet"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.04.004_bib18","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/en.2008-0086","article-title":"Spermatogenesis and sertoli cell activity in mice lacking sertoli cell receptors for follicle-stimulating hormone and androgen","volume":"149","author":"Abel","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/andr.262","article-title":"Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study","volume":"2","author":"Rastrelli","year":"2014","journal-title":"Andrology"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0015-0282(99)00322-2","article-title":"The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection","volume":"72","author":"Ashkenazi","year":"1999","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib21","first-page":"133","article-title":"Effect of follicle-stimulating hormone on sperm quality and pregnancy rate","volume":"6","author":"Baccetti","year":"2004","journal-title":"Asian J Androl"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0015-0282(16)56653-9","article-title":"Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone","volume":"61","author":"Bartoov","year":"1994","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0015-0282(99)00461-6","article-title":"Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in\u00a0vitro fertilization: the impact on sperm microstructure and fertilization potential","volume":"73","author":"Ben-Rafael","year":"2000","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0015-0282(03)02202-7","article-title":"Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection","volume":"80","author":"Caroppo","year":"2003","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib25","first-page":"588","article-title":"Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia","volume":"33","author":"Colacurci","year":"2012","journal-title":"J\u00a0Androl"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/cen.12770","article-title":"Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population","volume":"83","author":"Ding","year":"2015","journal-title":"Clinic Endocrinol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.04.004_bib27","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/humrep\/dew167","article-title":"Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study","volume":"31","author":"Simoni","year":"2016","journal-title":"Human Reprod (Oxford, England)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/12.1.24","article-title":"Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study","volume":"12","author":"Matorras","year":"1997","journal-title":"Human Reprod (Oxford, England)"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.fertnstert.2006.02.087","article-title":"Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study","volume":"86","author":"Paradisi","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.fertnstert.2005.03.055","article-title":"Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study","volume":"84","author":"Foresta","year":"2005","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0015-0282(01)02966-1","article-title":"Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility","volume":"77","author":"Foresta","year":"2002","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.fertnstert.2008.07.1766","article-title":"Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies","volume":"92","author":"Foresta","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2605.2010.01086.x","article-title":"The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms","volume":"34","author":"Selice","year":"2011","journal-title":"Int J Androl"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-65-6-1081","article-title":"Treatment of severe oligospermia with human chorionic gonadotropin\/human menopausal gonadotropin: a placebo-controlled, double blind trial","volume":"65","author":"Knuth","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib35","first-page":"1","article-title":"The effect of recombinant human follicle-stimulating hormone on sperm quality, chromatin status and clinical outcomes of infertile oligozoospermic men candidate for intracytoplasmic sperm injection: a randomized clinical trial","volume":"15","author":"Verdi","year":"2021","journal-title":"Int J fertility & sterility"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/UA.UA_37_19","article-title":"Efficacy of follicle-stimulating hormone as a treatment of severe idiopathic oligospermia: a retrospective study","volume":"12","author":"Aljuhayman","year":"2020","journal-title":"Urol Ann"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib37","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.fertnstert.2011.09.034","article-title":"Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter","volume":"96","author":"Ferlin","year":"2011","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"10.1016\/j.bpobgyn.2022.04.004_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(99)00228-2","article-title":"FSH in the treatment of oligozoospermia","volume":"161","author":"Foresta","year":"2000","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2022.04.004_bib39","first-page":"CD005071","article-title":"Gonadotrophins for idiopathic male factor subfertility","author":"Attia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005071.pub3","article-title":"Gonadotrophins for idiopathic male factor subfertility","author":"Attia","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib41","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1530\/EC-15-0050","article-title":"Follicle-stimulating hormone treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis","volume":"4","author":"Santi","year":"2015","journal-title":"Endocrine Connections"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/aja.aja_42_19","article-title":"FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies","volume":"22","author":"Cannarella","year":"2020","journal-title":"Asian J Androl"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.04.004_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/13685538.2019.1590696","article-title":"FSH therapy for idiopathic male infertility: four schemes are better than one","volume":"23","author":"La Vignera","year":"2020","journal-title":"Aging Male : Off J Int Soc Study Aging Male"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib44","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1530\/EJE-13-0624","article-title":"Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view","volume":"170","author":"Simoni","year":"2014","journal-title":"Eur J Endocrinol\/European Federation Endocrine Societies"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.04.004_bib45","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2012-1761","article-title":"Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male reproductive parameters","volume":"97","author":"Tuttelmann","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.04.004_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report","volume":"10","author":"Garrison","year":"2007","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.04.004_bib47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.04.004_bib48","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jval.2020.04.002","article-title":"Improving transparency to build trust in real-world secondary data studies for hypothesis testing-why, what, and how: recommendations and a road map from the real-world evidence transparency Initiative","volume":"23","author":"Orsini","year":"2020","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jval.2016.12.003","article-title":"Policies for use of real-world data in health technology assessment (HTA): a comparative study of six HTA agencies","volume":"20","author":"Makady","year":"2017","journal-title":"Value Health"},{"issue":"23","key":"10.1016\/j.bpobgyn.2022.04.004_bib50","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib51","first-page":"275","article-title":"Standardizing quality assessment of observational studies for decision making in health care","volume":"15","author":"Brixner","year":"2009","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib52","first-page":"191","article-title":"Using certification to promote uptake of real-world evidence by payers","volume":"22","author":"Segal","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1524-4733.2003.00242.x","article-title":"A\u00a0checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases","volume":"6","author":"Motheral","year":"2003","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.bpobgyn.2022.04.004_bib54","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.bpobgyn.2022.04.004_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1524-4733.2009.00601.x","volume":"12","author":"Cox","year":"2009","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.04.004_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41585-018-0003-3","article-title":"Genetics of male infertility","volume":"15","author":"Krausz","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.04.004_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11934-016-0627-x","article-title":"Genetics of male infertility","volume":"17","author":"Neto","year":"2016","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/jhrs.jhrs_115_21","article-title":"Genetics of male infertility - present and future: a narrative review","volume":"14","author":"Sudhakar","year":"2021","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib59","series-title":"More than 8 million babies born from IVF since the world's first in 1978: European IVF pregnancy rates now steady at around 36 percent, according to ESHRE monitoring","author":"De Geyter","year":"2018"},{"issue":"11","key":"10.1016\/j.bpobgyn.2022.04.004_bib60","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10815-019-01566-y","article-title":"Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry","volume":"36","author":"Scaravelli","year":"2019","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib61","doi-asserted-by":"crossref","first-page":"hoz004","DOI":"10.1093\/hropen\/hoz004","article-title":"Cumulative live birth rates following a 'freeze-all' strategy: a population-based study","volume":"2019","author":"Li","year":"2019","journal-title":"Hum Reprod Open"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib62","first-page":"556","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Human Reprod (Oxford, England)"},{"issue":"11","key":"10.1016\/j.bpobgyn.2022.04.004_bib63","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/humrep\/deab198","article-title":"International committee for monitoring assisted reproductive technologies world report: assisted reproductive technology","volume":"36","author":"Chambers","year":"2021","journal-title":"Human Reprod (Oxford, England)"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.04.004_bib64","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1471-0528.2006.00992.x","article-title":"Do clinical prediction models improve concordance of treatment decisions in reproductive medicine?","volume":"113","author":"van der Steeg","year":"2006","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib65","doi-asserted-by":"crossref","first-page":"613048","DOI":"10.3389\/fendo.2021.613048","article-title":"Mathematical modeling and simulation provides evidence for new strategies of ovarian stimulation","volume":"12","author":"Fischer","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.04.004_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa032","article-title":"ART in Europe, 2016: results generated from European registries by ESHRE","volume":"2020","author":"Wyns","year":"2020","journal-title":"Hum Reprod Open"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.04.004_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00404-018-4987-y","article-title":"Bologna criteria are predictive for ovarian response and live birth in subsequent ovarian stimulation cycles","volume":"299","author":"Yakin","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.04.004_bib68","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/humrep\/des338","article-title":"Best practices of ASRM and ESHRE: a journey through reproductive medicine","volume":"27","author":"Gianaroli","year":"2012","journal-title":"Human Reprod (Oxford, England)"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40738-020-00081-4","article-title":"The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain","volume":"6","author":"Ferrando","year":"2020","journal-title":"Fertil Res Pract"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib70","first-page":"9","article-title":"Real-world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment","volume":"2","author":"Jellerette-Nolan","year":"2021","journal-title":"F\u00a0S Rep"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.rbmo.2017.10.102","article-title":"Does ovarian stimulation regimen affect IVF outcome? a two-centre, real-world retrospective study using predominantly cleavage-stage, single embryo transfer","volume":"36","author":"Karlstr\u00f6m","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.urology.2009.05.043","article-title":"Sperm DNA damage: correlation to severity of semen abnormalities","volume":"74","author":"Moskovtsev","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12610-018-0070-6","article-title":"Sperm aneuploidy and DNA fragmentation in unexplained recurrent pregnancy loss: a multicenter case-control study","volume":"28","author":"Esquerr\u00e9-Lamare","year":"2018","journal-title":"Basic Clinical Androl"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.04.004_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/andr.12724","article-title":"An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men","volume":"8","author":"Esteves","year":"2020","journal-title":"Andrology"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib75","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa243","article-title":"Prospects for FSH treatment of male infertility","author":"Simoni","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabolism"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.04.004_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/aja.aja_91_20","article-title":"Influence of sperm morphology on pregnancy outcome and offspring in in vitro fertilization and intracytoplasmic sperm injection: a matched case-control study","volume":"23","author":"Zhou","year":"2021","journal-title":"Asian J Androl"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib77","series-title":"AIFA. Note 74","year":"2010"},{"key":"10.1016\/j.bpobgyn.2022.04.004_bib78","article-title":"Use of follicle-stimulating hormone for the male partner of idiopathic infertile couples in Italy: results from a multicentre, observational, clinical practice survey","author":"Santi","year":"2019","journal-title":"Andrology"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:15:18Z","timestamp":1761498918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693422000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":78,"alternative-id":["S1521693422000682"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.04.004","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}